Green Alpha Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Green Alpha Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 04, 2024	SELL	$0.35 - $0.53 $41,413 - $62,711	-118,324 Reduced 20.76%	451,725 $230,000
Q3 2023 Oct 10, 2023	BUY	$0.38 - $0.58 $147,345 - $224,896	387,752 Added 212.7%	570,049 $222,000
Q2 2023 Jul 06, 2023	BUY	$0.39 - $0.94 $14,038 - $33,837	35,997 Added 24.6%	182,297 $82,000
Q1 2023 Apr 06, 2023	SELL	$0.79 - $1.91 $612 - $1,480	-775 Reduced 0.53%	146,300 $119,000
Q4 2022 Jan 12, 2023	SELL	$1.41 - $2.5 $430 - $762	-305 Reduced 0.21%	147,075 $0
Q3 2022 Oct 14, 2022	BUY	$1.66 - $2.79 $27,853 - $46,813	16,779 Added 12.85%	147,380 $254,000
Q2 2022 Jul 08, 2022	BUY	$1.44 - $3.98 $74,043 - $204,647	51,419 Added 64.94%	130,601 $226,000
Q1 2022 Apr 19, 2022	BUY	$2.97 - $5.2 $19,408 - $33,982	6,535 Added 9.0%	79,182 $284,000
Q4 2021 Jan 12, 2022	BUY	$4.99 - $7.46 $37,320 - $55,793	7,479 Added 11.48%	72,647 $363,000
Q3 2021 Oct 12, 2021	BUY	$7.16 - $9.69 $18,630 - $25,213	2,602 Added 4.16%	65,168 $467,000
Q2 2021 Jul 22, 2021	BUY	$6.23 - $10.03 $389,786 - $627,536	62,566 New	62,566 $580,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.